We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The liver cancer drug market size is expected to grow from USD870 million (2017) to nearly USD4 billion (2027), which will benefit from the marketing of other 8 high-priced biologics and the extensive promotion of nivolumab as a first-line therapy.
The report to identify and analyse emerging trends along with major drivers, challenges and opportunities in the global influenza market. Also highlights key development and new drugs launched by various companies across the globe.